Concepedia

Michael P. Maher

MP

Statistics

Publications

24

Citations

1.3K

H-Index

19

Active since

1985

Affiliations

Johnson & Johnson (United States)(Current)

Janssen (United States)

Janssen (Belgium)

Vertex Pharmaceuticals (United States)

California Institute of Technology

Michael P. Maher is an author at Johnson & Johnson (United States) specializing in pharmacology, drug discovery, and ion channels.

ORCID

Publications per year

1985–2021

24

Publications

24

The neurochip: a new multielectrode device for stimulating and recording from cultured neurons

Michael P. Maher, Jerome Pine, John A. Wright et al. · Journal of Neuroscience Methods · 1999 · 323 citations

, , +12

Characterization of voltage-gated sodium-channel blockers by electrical stimulation and fluorescence detection of membrane potential

Chien-Jung Huang, A. Harootunian, Michael P. Maher et al. · Nature Biotechnology · 2006 · 133 citations

, , +17

Discovery and Characterization of AMPA Receptor Modulators Selective for TARP-γ8

Michael P. Maher, Michael K. Ameriks, Brad M. Savall et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 99 citations

, , +15

Phase slip in charge-density-wave systems

Satish Ramakrishna, Michael P. Maher, Vinay Ambegaokar et al. · Physical Review Letters · 1992 · 81 citations · Full text

, , +17

Pharmacology and Antitussive Efficacy of 4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic Acid (5-Trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a Transient Receptor Potential Vanilloid 1 Antagonist in Guinea Pigs

Anindya Bhattacharya, Brian Scott, Nadia Nasser et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 74 citations

, , +14

1–5 of 24